OB Express 2.0
OB Express 2.0 Summary
OB Express 2.0 is a mobile Android app in Education by Food and Drug Administration. Released in May 2017 (9 years ago). It has about 21.3K+ installs and 52 ratings with a 4.08★ (good) average. Based on AppGoblin estimates, it reaches roughly 56 monthly active users . Store metadata: updated Jun 27, 2017.
Recent activity: 3.00 installs this week (15 over 4 weeks) showing steady growth View trends →
Store info: Last updated on Google Play on Jun 27, 2017 .
4.08★
Ratings: 52
Screenshots
App Description
FDA Orange Book Express
*** Important note: We regret to inform you our mobile app will no longer be available as of 10/03/2024. In its place, we are excited to offer you a responsive web design option via the Orange Book.
The Orange Book website provides a seamless experience, including access to all our features and services, online and on your mobile devices. You may access the site in its entirety at the following location: https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm. ***
We appreciate your understanding and support during this transition.
============================================
New in this version:
• Search results and drug listings now clarify which listed drugs are reference listed drugs (RLDs) and which are reference standards.
• The application now uses HTTPS encryption to provide a secure connection.
With FDA’s Orange Book Express app, it’s now faster and easier to find information about:
• Drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA)
• Information about patents and exclusivity
Orange Book Express allows you to:
• Search by Active Ingredient or Proprietary Name; Applicant Holder (Firm); Application Number; or Patent Number.
• Search all marketing statuses (Rx, OTC, Discontinued) with one search.
• Look up patent and exclusivity information.
• Identify Reference Listed Drugs (RLDs) and determine if a drug product has a therapeutic equivalent.
• Browse Patent Delistings and Newly Added Patents.
